Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A broad market index fund offers simple diversification and low costs, making it a practical choice for retirement portfolios seeking steady growth.
28,528 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Chart Industries just delivered a sweeping earnings milestone, but a sizable investor trimmed a multi-million dollar ...
Investors scanned the markets as AMC faced dilution concerns that weighed on sentiment. This piece breaks down what h...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
Two very different retail giants compete for investors' attention in 2026. This guide breaks down whether Abercrombie...
A Trump-themed memecoin crash leaves close to a million holders deep in losses, even as the president discloses hefty...
Stratasys has long been a trailblazer in 3D printing, but the road ahead is proving tougher amid competition and cost...
OpenAI has released GPT-5.6 to a limited group of users, signaling a cautious, policy-conscious rollout. This cautiou...
El Salvador continues to pursue a plan to buy one Bitcoin per day, even as an IMF loan program restricts public-secto...
Rising US energy costs are prompting a rethink on where to place AI data centers. Gulf-backed capacity powered by oil...
Homeowners push for property tax relief as states weigh cuts, but funding gaps and school budgets complicate the poli...
NWN’s Q1 2026 results reveal how the company balances growth with profitability. This analysis breaks down the number...